Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.29
-2.27 %
$ 173 M
Market Cap
9.92
P/E
1. INTRINSIC VALUE
Balance Sheet
Organigram Global Inc.
| Current Assets | 262 M |
| Cash & Short-Term Investments | 108 M |
| Receivables | 37.2 M |
| Other Current Assets | 118 M |
| Non-Current Assets | 146 M |
| Long-Term Investments | 40.7 M |
| PP&E | 96.2 M |
| Other Non-Current Assets | 8.68 M |
| Current Liabilities | 53.3 M |
| Accounts Payable | 47.1 M |
| Short-Term Debt | 1.09 M |
| Other Current Liabilities | 5.14 M |
| Non-Current Liabilities | 48.5 M |
| Long-Term Debt | 3.37 M |
| Other Non-Current Liabilities | 45.2 M |
EFFICIENCY
Earnings Waterfall
Organigram Global Inc.
| Revenue | 160 M |
| Cost Of Revenue | 112 M |
| Gross Profit | 47.5 M |
| Operating Expenses | 83.2 M |
| Operating Income | -35.7 M |
| Other Expenses | 9.77 M |
| Net Income | -45.4 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Organigram Global Inc.
| Net Income | -45.4 M |
| Depreciation & Amortization | 12.1 M |
| Capital Expenditures | -5.34 M |
| Stock-Based Compensation | 7.18 M |
| Change in Working Capital | 15 M |
| Others | 42.1 M |
| Free Cash Flow | -1.47 M |
Wall Street Analysts Price Targets
Organigram Global Inc.
OGI has no price targets from Wall Street.
4. DIVIDEND
ANALYSIS
OGI does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Organigram Global Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
June 2025 Watchlist: Best Canadian Cannabis Stocks for Growth
As of June 2025, the U.S. cannabis industry continues its rapid expansion. Projections estimate the market will reach approximately $45 billion in revenue this year. This growth is fueled by increasing consumer demand, introducing innovative products, and technological advancements in cultivation and production. Despite federal prohibition, 24 states have legalized adult-use cannabis, and 39 states have legalized medical cannabis. However, federal legalization efforts face challenges. In May 2025, the 1st U.S. Circuit Court of Appeals upheld the federal ban on marijuana, rejecting a legal challenge by several Massachusetts cannabis businesses. This decision underscores the ongoing tension between federal law and evolving state cannabis regulations. Additionally, while the Biden administration has proposed reclassifying marijuana to a less restricted category, the outcome remains uncertain, especially under a new administration.
marijuanastocks.com
- 1 month ago
Organigram Global Announces CEO Succession Plan
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today that Ms. Beena Goldenberg, CEO, Organigram, will be retiring at the conclusion of the Company's current fiscal year ending September 30, 2025. Until this date, Ms. Goldenberg will continue in her role as CEO and as a member of the Company's Board of Directors (the “Board”) to advance Organigram's strategic objectives, including.
businesswire.com
- 1 month ago
Organigram Global Reports Record Q2 2025 Revenues As Global Footprint Expands
Organigram Global reported record-high revenues for Q2 and improved net income. The company is now selling cannabis beverages in Canada and hemp-derived cannabis beverages in the US. Organigram Global is ramping up its facilities in Canada to meet international demand.
seekingalpha.com
- 1 month ago
OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised)
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
zacks.com
- 1 month ago
Organigram Lights Up Q2 With 74% Sales Surge, Profitable Turn
Cannabis grower Organigram Holdings Inc OGI reported second-quarter 2025 net sales of $45.7 million (approximately CA$65.6 million). That's up 74% year-over-year, beating the consensus of $42.28 million.
benzinga.com
- 1 month ago
Organigram Global Inc. (OGI) Q2 2025 Earnings Call Transcript
Organigram Global Inc. (NASDAQ:OGI ) Q2 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Max Schwartz - Investor Relations Beena Goldenberg - Chief Executive Officer Greg Guyatt - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today.
seekingalpha.com
- 1 month ago
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago.
zacks.com
- 1 month ago
Organigram Reports Record Second Quarter Fiscal 2025 Results
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 (“Q2 Fiscal 2025”). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6, 2024. Q2 FISCAL 2025 HIGHLIGHTS Gross revenue increased 79% to $102.8 million from $57.4 million in.
businesswire.com
- 1 month ago
Organigram Global's Collective Project Wins Big at the 2025 High Spirits Awards in California
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce that its recently acquired business, Collective Project, has won recognition at the 2025 High Spirits Awards only a few short months following the launch of the brand in the U.S. The brand received a gold award for Blood Orange, Yuzu & Vanilla and a platinum award for Mango, Pineapple & Coconut hemp-derived THC b.
businesswire.com
- 1 month ago
Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce it has been named Exporter of the Year by Opportunities New Brunswick (“ONB”) as part of the 2025 New Brunswick Export Awards, ONB's flagship annual event recognizing the successes and innovative approaches of New Brunswick's many exporting companies. This honour recognizes Organigram's significant growth in internationa.
businesswire.com
- 1 month ago
Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2025 ended March 31, 2025, on Monday, May 12, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Monday, May 12, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use thi.
businesswire.com
- 2 months ago
Organigram Global's Products Recognized at the CNB Awards
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce that three of its consumer brands — SHRED, Edison, and Trailblazer — earned honours at the recent CNB Leadership Conference and the Cannabis NB Cup. Inspired by the legacy events that have shaped cannabis culture over the years, the Cannabis NB Cup celebrates the best in grow — with winners chosen by those who matter mos.
businesswire.com
- 2 months ago
8. Profile
Summary
Organigram Global Inc. OGI
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 173 M
Dividend Yield
0.00%
Description
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Contact
35 English Drive, Moncton, NB, E1E 3X3
https://www.organigram.ca
IPO
Date
May 21, 2019
Employees
1093
Officers
Ms. Nathalie Batten Kubrick
Executive Vice President of Operations
Max Schwartz
Director of Investor Relations
Ms. Helen Martin
Chief Legal Officer & Corporate Secretary
Mr. Greg Guyatt C.A., CPA
Chief Financial Officer
Mr. Paolo De Luca C.A., C.F.A
Chief Strategy Officer
Mr. Geoffrey John Riggs
Chief Information Officer
Mr. Gregory Engel
Special Advisor
Ms. Katrina May McFadden
Chief People Officer
Ms. Beena G. Goldenberg
Chief Executive Officer & Director
Mr. Timothy Emberg
Chief Commercial Officer